etanercept
RESULTS: Reports from clinical       trials of patients with refractory RA indicate that etanercept significantly       improves measures of disease activity, including swollen and tender joint counts,       morning stiffness, pain, and erythrocyte sedimentation rate, compared with       placebo.
RESULTS: Reports from clinical       trials of patients with refractory RA indicate that  @SUBJECT$  significantly       improves measures of disease activity, including swollen and tender joint counts,       morning stiffness, pain, and erythrocyte sedimentation rate,  @PREDICAT$  with        @OBJECT$ .